FDA Issues New Anemia Drug Warnings
The FDA issued a black box warning—its strongest—Friday for Aransep, Epogen and Procrit, all erythropoiesis-stimulating agents or ESAs. The agency said that physicians should monitor red blood cell levels and carefully weigh the risks of using the drugs against transfusion risks.
The FDA said that recently completed studies of the drugs describe an increased risk of death, blood...
To view the full article, register now.